American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 40-47.e2 , July 2010

Association of Risk Factors for Choroidal Neovascularization in Age-Related Macular Degeneration With Decreased Foveolar Choroidal Circulation

,Accepted 29 January 2010.

References 

  1. Congdon N, O'Colmain B, Klaver CC, et al. Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485
  2. Augood CA, Vingerling JR, de Jong PT, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol. 2006;124(4):529–535
  3. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564–572
  4. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology. 2002;109(6):1092–1097
  5. Mukesh BN, Dimitrov PN, Leikin S, et al. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Ophthalmology. 2004;111(6):1176–1182
  6. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28(1):1–18
  7. Coleman HR, Chan CC, Ferris FL, Chew EY. Age-related macular degeneration. Lancet. 2008;372(9652):1835–1845
  8. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 2007;14(4):184–187
  9. Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol. 2000;118(3):351–358
  10. Age-Related Eye Disease Study Group. Risk factors associated with age-related macular degeneration: a case-control study in the age related eye disease study (Age-Related Eye Disease Study Report Number 3). Ophthalmology. 2000;107(12):2224–2232
  11. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. Ophthalmology. 2003;110(6):1273–1280
  12. Hogg RE, Woodside JV, Gilchrist SE, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology. 2008;115(6):1046–1052
  13. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration (Pooled findings from 3 continents). Ophthalmology. 2004;111(7):1280–1287
  14. Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8(4):237–249
  15. Chaine G, Hullo A, Sahel J, et al. Case-control study of the risk factors for age related macular degeneration. Br J Ophthalmol. 1998;82(9):996–1002
  16. Nitsch D, Evans J, Roderick PJ, Smeeth L, Fletcher AE. Associations between chronic kidney disease and age-related macular degeneration. Ophthalmic Epidemiol. 2009;16(3):181–186
  17. Ikram MK, van Leeuwen R, Vingerling JR, et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44(9):3778–3782
  18. Au Eong KG, Haller JA. Risk factors for age-related macular degeneration and choroidal neovascularization. In:  Lim JI editors. Age-Related Macular Degeneration. New York: Marcel Dekker, Inc; 2002;p. 389–395
  19. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration AREDS Report No. 17. Arch Ophthalmol. 2005;123(11):1484–1498
  20. Grunwald JE, Hariprasad SM, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39(2):385–390
  21. Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci. 2005;46(3):1033–1038
  22. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49(1):358–363
  23. Riva CE, Cranstoun SD, Grunwald JE, Petrig BL. Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci. 1994;35(13):4273–4281
  24. Riva CE, Harino S, Petrig BL, Shonat RD. Laser-Doppler flowmetry in the optic nerve. Exp Eye Res. 1992;55(3):499–506
  25. Riva CE. Basic principles of laser Doppler flowmetry and application to the ocular circulation. Int Ophthalmol. 2001;23(4-6):183–189
  26. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–130
  27. The CAPT Research Group. Risk factors for choroidal neovascularization and geographic atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology. 2008;115(9):1474–1479
  28. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58(3):353–363
  29. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116(2):150–154
  30. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994;35(6):2857–2864
  31. Ehrlich R, Kheradiya NS, Winston DM, Moore DB, Wirostko B, Harris A. Age-related ocular vascular changes. Graefes Arch Clin Exp Ophthalmol. 2009;247(5):583–591
  32. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol. 2006;90(3):342–346
  33. Ross RD, Barofsky JM, Cohen G, et al. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. Am J Ophthalmol. 1998;125(1):71–80
  34. Bressler NM, Silva J, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14(2):130–142
  35. Boker T, Fang T, Steinmetz R. Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration. Ger J Ophthalmol. 1993;2(1):10–13
  36. Friedman E, Krupsky S, Lane A, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995;102(4):640–646
  37. Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124(5):677–682
  38. Kiel JW, Reiner AJ. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38(7):1290–1292
  39. Fujihara M, Nagai N, Sussan TE, Biswal S, Handa JT. Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS ONE. 2008;3(9):e3119

PII: S0002-9394(10)00112-1

doi: 10.1016/j.ajo.2010.01.041

American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 40-47.e2 , July 2010

Article Tools

* Image Usage & Resolution